COO Nov 2024 165.000 call
| Previous close | 175.00 |
| Open | N/A |
| Bid | 216.00 |
| Ask | 226.00 |
| Strike | 165.00 |
| Expiry date | 2024-11-15 |
| Day's range | 175.00 - 175.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
GlobeNewswireCooperCompanies to Participate in the Jefferies Global Healthcare Conference
SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 1:30 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos
ZacksAspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
Aspira (AWH) delivered earnings and revenue surprises of -8.33% and 2.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
CooperCompanies to Participate in the William Blair Growth Stock Conference
SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. About C
